Nomura Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.95M | Sell |
144,682
-239,521
| -62% | -$13.2M | 0.02% | 499 |
|
2025
Q1 | $27.2M | Sell |
384,203
-28,096
| -7% | -$1.99M | 0.08% | 241 |
|
2024
Q4 | $27.1M | Sell |
412,299
-73,310
| -15% | -$4.82M | 0.08% | 239 |
|
2024
Q3 | $34.1M | Buy |
485,609
+110,683
| +30% | +$7.78M | 0.11% | 203 |
|
2024
Q2 | $30.9M | Sell |
374,926
-61,829
| -14% | -$5.09M | 0.11% | 203 |
|
2024
Q1 | $38.1M | Buy |
436,755
+58,984
| +16% | +$5.15M | 0.14% | 174 |
|
2023
Q4 | $36.4M | Sell |
377,771
-4,323
| -1% | -$417K | 0.15% | 159 |
|
2023
Q3 | $33.8M | Buy |
382,094
+92,045
| +32% | +$8.14M | 0.16% | 153 |
|
2023
Q2 | $25.1M | Buy |
290,049
+69,328
| +31% | +$6.01M | 0.12% | 207 |
|
2023
Q1 | $21.5M | Buy |
220,721
+124,701
| +130% | +$12.1M | 0.11% | 213 |
|
2022
Q4 | $9.94M | Sell |
96,020
-7,815
| -8% | -$809K | 0.06% | 313 |
|
2022
Q3 | $8.8M | Buy |
103,835
+5,675
| +6% | +$481K | 0.06% | 327 |
|
2022
Q2 | $8.13M | Buy |
98,160
+6,990
| +8% | +$579K | 0.05% | 343 |
|
2022
Q1 | $7.03M | Buy |
91,170
+1,832
| +2% | +$141K | 0.04% | 405 |
|
2021
Q4 | $7.89M | Buy |
89,338
+11,600
| +15% | +$1.02M | 0.04% | 378 |
|
2021
Q3 | $6.01M | Sell |
77,738
-5,171
| -6% | -$400K | 0.03% | 423 |
|
2021
Q2 | $6.92M | Sell |
82,909
-96,361
| -54% | -$8.04M | 0.04% | 396 |
|
2021
Q1 | $13.5M | Buy |
179,270
+8,900
| +5% | +$672K | 0.09% | 250 |
|
2020
Q4 | $14.9M | Sell |
170,370
-208,110
| -55% | -$18.2M | 0.1% | 211 |
|
2020
Q3 | $28.8M | Buy |
378,480
+113,808
| +43% | +$8.66M | 0.22% | 99 |
|
2020
Q2 | $32.6M | Buy |
264,672
+184,647
| +231% | +$22.8M | 0.28% | 81 |
|
2020
Q1 | $6.76M | Buy |
80,025
+2,003
| +3% | +$169K | 0.07% | 246 |
|
2019
Q4 | $6.6M | Buy |
78,022
+7
| +0% | +$592 | 0.06% | 296 |
|
2019
Q3 | $5.26M | Buy |
78,015
+2,517
| +3% | +$170K | 0.05% | 322 |
|
2019
Q2 | $6.47M | Sell |
75,498
-200
| -0.3% | -$17.1K | 0.06% | 272 |
|
2019
Q1 | $6.72M | Sell |
75,698
-7,141
| -9% | -$634K | 0.07% | 261 |
|
2018
Q4 | $7.05M | Sell |
82,839
-795
| -1% | -$67.7K | 0.08% | 228 |
|
2018
Q3 | $8.11M | Sell |
83,634
-34,384
| -29% | -$3.33M | 0.08% | 222 |
|
2018
Q2 | $11.1M | Buy |
118,018
+4,478
| +4% | +$422K | 0.12% | 157 |
|
2018
Q1 | $9.21M | Buy |
113,540
+5,733
| +5% | +$465K | 0.1% | 177 |
|
2017
Q4 | $9.61M | Buy |
107,807
+4,927
| +5% | +$439K | 0.11% | 174 |
|
2017
Q3 | $9.57M | Buy |
102,880
+7,337
| +8% | +$683K | 0.12% | 167 |
|
2017
Q2 | $8.68M | Buy |
95,543
+384
| +0.4% | +$34.9K | 0.12% | 178 |
|
2017
Q1 | $8.35M | Buy |
95,159
+3,390
| +4% | +$298K | 0.12% | 187 |
|
2016
Q4 | $7.6M | Buy |
91,769
+17,666
| +24% | +$1.46M | 0.14% | 174 |
|
2016
Q3 | $6.86M | Buy |
74,103
+16,012
| +28% | +$1.48M | 0.12% | 191 |
|
2016
Q2 | $4.52M | Buy |
58,091
+23,406
| +67% | +$1.82M | 0.08% | 238 |
|
2016
Q1 | $2.86M | Buy |
34,685
+15,996
| +86% | +$1.32M | 0.05% | 321 |
|
2015
Q4 | $1.96M | Sell |
18,689
-10,984
| -37% | -$1.15M | 0.04% | 397 |
|
2015
Q3 | $3.13M | Buy |
29,673
+3,023
| +11% | +$318K | 0.06% | 283 |
|
2015
Q2 | $3.65M | Buy |
26,650
+1,400
| +6% | +$191K | 0.07% | 268 |
|
2015
Q1 | $3.15M | Buy |
25,250
+1,230
| +5% | +$153K | 0.06% | 290 |
|
2014
Q4 | $2.17M | Sell |
24,020
-330
| -1% | -$29.8K | 0.04% | 374 |
|
2014
Q3 | $1.76M | Buy |
24,350
+2,000
| +9% | +$144K | 0.03% | 403 |
|
2014
Q2 | $1.39M | Hold |
22,350
| – | – | 0.03% | 475 |
|
2014
Q1 | $1.52M | Buy |
22,350
+8,000
| +56% | +$546K | 0.03% | 437 |
|
2013
Q4 | $1.01M | Sell |
14,350
-11,100
| -44% | -$781K | 0.02% | 549 |
|
2013
Q3 | $1.84M | Buy |
25,450
+4,200
| +20% | +$303K | 0.03% | 398 |
|
2013
Q2 | $1.19M | Buy |
+21,250
| New | +$1.19M | 0.02% | 528 |
|